Resistin is linked to inflammation, and leptin to metabolic syndrome, in women with inflammatory arthritis

References

• Sidiropoulos PI, Karvounaris SA, Boumpas DT. Metabolic syndrome in rheumatic diseases: epidemiology, pathophysiology, and clinical implications. Arthritis Res Ther 2008;10:207.
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet P, Shaw J. Metabolic syndrome – a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006;23:469–80.
   PubMed Web of Science ®Google Scholar
• Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988–1994. Arch Intern Med 2003;163:427–36.
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Mangalat D, Korbut R. Adipocytokines – novel link between inflammation and vascular function? J Physiol Pharmacol 2006;57:505–28.
   PubMed Web of Science ®Google Scholar
• Hotamisligil GS. Inflammation and metabolic disorders. Nature 2006;444:860–7.
   PubMed Web of Science ®Google Scholar
• Toussirot E, Streit G, Wendling D. The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem 2007;14:1095–100.
   PubMed Web of Science ®Google Scholar
• Rantala AO, Kauma H, Lilja M, Savolainen MJ, Reunanen A, Kesaniemi YA. Prevalence of the metabolic syndrome in drug-treated hypertensive patients and control subjects. J Intern Med 1999;245:163–74.
   PubMed Web of Science ®Google Scholar
• Karvounaris SA, Sidiropoulos PI, Papadakis JA, Spanakis EK, Bertsias GK, Kritikos HD, Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis 2007;66:28–33.
   PubMed Web of Science ®Google Scholar
• Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T, Shintani A, Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 2008;196:756–63.
   PubMed Web of Science ®Google Scholar
• Malesci D, Niglio A, Mennillo GA, Buono R, Valentini G, La Montagna G. High prevalence of metabolic syndrome in patients with ankylosing spondylitis. Clin Rheumatol 2007;26:710–14.
   PubMed Web of Science ®Google Scholar
• Saltevo J, Vanhala M, Kautiainen H, Kumpusalo E, Laakso M. Association of C-reactive protein, interleukin-1 receptor antagonist and adiponectin with the metabolic syndrome. Mediators Inflamm 2007;2007:93573.
   PubMed Web of Science ®Google Scholar
• Milan G, Granzotto M, Scarda A, Calcagno A, Pagano C, Federspil G, Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes Res 2002;10:1095–103.
   PubMedGoogle Scholar
• Savage DB, Sewter CP, Klenk ES, Segal DG, Vidal-Puig A, Considine RV, Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans. Diabetes 2001;50:2199–202.
   PubMed Web of Science ®Google Scholar
• Patel L, Buckels AC, Kinghorn IJ, Murdock PR, Holbrook JD, Plumpton C, Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators. Biochem Biophys Res Commun 2003;300:472–6.
   PubMed Web of Science ®Google Scholar
• Norata GD, Ongari M, Garlaschelli K, Raselli S, Grigore L, Catapano AL. Plasma resistin levels correlate with determinants of the metabolic syndrome. Eur J Endocrinol 2007;156:279–84.
   PubMed Web of Science ®Google Scholar
• Tarkowski A, Bjersing J, Shestakov A, Bokarewa MI. Resistin competes with lipopolysaccharide for binding to Toll-like receptor 4. J Cell Mol Med 2010;14:1419–31.
   PubMed Web of Science ®Google Scholar
• Kusminski CM, da Silva NF, Creely SJ, Fisher FM, Harte AL, Baker AR, The in vitro effects of resistin on the innate immune signaling pathway in isolated human subcutaneous adipocytes. J Clin Endocrinol Metab 2007;92:270–6.
   Google Scholar
• Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005;174:5789–95.
   PubMed Web of Science ®Google Scholar
• !?A3B2 twb=0.20w?>Schaffler A, Ehling A, Neumann E, Herfarth H, Tarner I, Scholmerich J, Adipocytokines in synovial fluid. J Am Med Assoc 2003;290:1709–10.
   Google Scholar
• Senolt L, Housa D, Vernerova Z, Jirasek T, Svobodova R, Veigl D, Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis 2007;66:458–63.
   PubMed Web of Science ®Google Scholar
• Rho YH, Solus J, Sokka T, Oeser A, Chung CP, Gebretsadik T, Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. Arthritis Rheum 2009;60:1906–14.
   PubMed Web of Science ®Google Scholar
• Otero M, Lago R, Gomez R, Lago F, Dieguez C, Gomez-Reino JJ, Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritis. Ann Rheum Dis 2006;65:1198–201.
   PubMed Web of Science ®Google Scholar
• Forsblad d’Elia H, Pullerits R, Carlsten H, Bokarewa M. Resistin in serum is associated with higher levels of IL-1Ra in post-menopausal women with rheumatoid arthritis. Rheumatology (Oxford) 2008;47:1082–7.
   PubMed Web of Science ®Google Scholar
• Kunnari A, Ukkola O, Päivänsalo M, Kesäniemi YA. High plasma resistin level is associated with enhanced highly sensitive C-reactive protein and leukocytes. J Clin Endocrinol Metab 2006;91:2755–60.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Garcia-Unzueta MT, Gonzalez-Juanatey C, Miranda-Filloy JA, Vazquez-Rodriguez TR, De Matias JM, Anti-TNF-alpha therapy modulates resistin in patients with rheumatoid arthritis. Clin Exp Rheumatol 2008;26:311–16.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse obese gene and its human homologue. Nature 1994;372:425–32.
   PubMed Web of Science ®Google Scholar
• Munzberg H, Myers MG Jr. Molecular and anatomical determinants of central leptin resistance. Nat Neurosci 2005;8:566–70.
   PubMed Web of Science ®Google Scholar
• Matarese G, Moschos S, Mantzoros CS. Leptin in immunology. J Immunol 2005;174:3137–42.
   PubMed Web of Science ®Google Scholar
• Fruhbeck G. Intracellular signalling pathways activated by leptin. Biochem J 2006;393:7–20.
   PubMed Web of Science ®Google Scholar
• Lam QL, Lu L. Role of leptin in immunity. Cell Mol Immunol 2007;4:1–13.
   PubMed Web of Science ®Google Scholar
• Park MC, Lee SW, Choi ST, Park YB, Lee SK. Serum leptin levels correlate with interleukin-6 levels and disease activity in patients with ankylosing spondylitis. Scand J Rheumatol 2007;36:101–6.
   PubMed Web of Science ®Google Scholar
• Otero M, Gomez Reino JJ, Gualillo O. Synergistic induction of nitric oxide synthase type II: in vitro effect of leptin and interferon-gamma in human chondrocytes and ATDC5 chondrogenic cells. Arthritis Rheum 2003;48:404–9.
   PubMedGoogle Scholar
• Otero M, Lago R, Lago F, Reino JJ, Gualillo O. Signalling pathway involved in nitric oxide synthase type II activation in chondrocytes: synergistic effect of leptin with interleukin-1. Arthritis Res Ther 2005;7:R581–91.
   PubMed Web of Science ®Google Scholar
• Iliopoulos D, Malizos KN, Tsezou A. Epigenetic regulation of leptin affects MMP-13 expression in osteoarthritic chondrocytes: possible molecular target for osteoarthritis therapeutic intervention. Ann Rheum Dis 2007;66:1616–21.
   PubMed Web of Science ®Google Scholar
• Simopoulou T, Malizos KN, Iliopoulos D, Stefanou N, Papatheodorou L, Ioannou M, Differential expression of leptin and leptin's receptor isoform (Ob-Rb) mRNA between advanced and minimally affected osteoarthritic cartilage; effect on cartilage metabolism. Osteoarthritis Cartilage 2007;15:872–83.
   PubMed Web of Science ®Google Scholar
• Vuolteenaho K, Koskinen A, Nieminen R, Moilanen T, Moilanen E. Leptin enhances MMP-1, MMP-3 and MMP-13 production in human OA cartilage. Osteoarthritis Cartilage 2008;16(Suppl 4):S107.
   Google Scholar
• Vuolteenaho K, Koskinen A, Kukkonen M, Nieminen R, Paivarinta U, Moilanen T, Leptin enhances synthesis of proinflammatory mediators in human osteoarthritic cartilage – mediator role of NO in leptin-induced PGE2, IL-6, and IL-8 production. Mediators Inflamm 2009;2009:345838.
   PubMed Web of Science ®Google Scholar
• Bokarewa M, Bokarew D, Hultgren O, Tarkowski A. Leptin consumption in the inflamed joints of patients with rheumatoid arthritis. Ann Rheum Dis 2003;62:952–6.
   PubMed Web of Science ®Google Scholar
• Lee SW, Park MC, Park YB, Lee SK. Measurement of the serum leptin level could assist disease activity monitoring in rheumatoid arthritis. Rheumatol Int 2007;27:537–40.
   PubMed Web of Science ®Google Scholar
• Gannage-Yared MH, Khalife S, Semaan M, Fares F, Jambart S, Halaby G. Serum adiponectin and leptin levels in relation to the metabolic syndrome, androgenic profile and somatotropic axis in healthy non-diabetic elderly men. Eur J Endocrinol 2006;155:167–76.
   PubMed Web of Science ®Google Scholar
• Buckwalter JA, Saltzman C, Brown T. The impact of osteoarthritis: implications for research. Clin Orthop 2004;427(Suppl):S6–15.
   PubMedGoogle Scholar
• Gabrielsson BG, Johansson JM, Lönn M, Jernås M, Olbers T, Peltonen M, High expression of complement components in omental adipose tissue in obese men. Obes Res 2003; 11:699–708.
   PubMedGoogle Scholar
• Moilanen E, Hannonen P, Kauppi M, Korpela M, Mottonen T, Kaipiainen-Seppanen O, Pretreatment levels of adipokines adipsin and leptin are associated with remission rates in early RA (NEO-RaCo study). Scand J Rheumatol 2009;38:405.
   Web of Science ®Google Scholar
• Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol 2005;115:911–20.
   PubMed Web of Science ®Google Scholar
• Sun Y, Xun K, Wang C, Zhao H, Bi H, Chen X, Adiponectin, an unlocking adipocytokine. Cardiovasc Ther 2009;27:59–75.
   PubMed Web of Science ®Google Scholar
• Tang CH, Chiu YC, Tan TW, Yang RS, Fu WM. Adiponectin enhances IL-6 production in human synovial fibroblast via an AdipoR1 receptor, AMPK, p38, and NF-kappa B pathway. J Immunol 2007;179:5483–92.
   PubMed Web of Science ®Google Scholar
• Lee SW, Kim JH, Park MC, Park YB, Lee SK. Adiponectin mitigates the severity of arthritis in mice with collagen-induced arthritis. Scand J Rheumatol 2008;37:260–8.
   PubMed Web of Science ®Google Scholar
• Giles JT, Allison M, Bingham CO, Scott WM, Bathon JM. Adiponectin is a mediator of the inverse association of adiposity with radiographic damage in rheumatoid arthritis. Arthritis Rheum 2009;61:1248–56.
   PubMed Web of Science ®Google Scholar
• Gonzalez-Gay MA, Llorca J, Garcia-Unzueta MT, Gonzalez-Juanatey C, De Matias JM, Martin J, High-grade inflammation, circulating adiponectin concentrations and cardiovascular risk factors in severe rheumatoid arthritis. Clin Exp Rheumatol 2008;26:596–603.
   PubMed Web of Science ®Google Scholar
• Senolt L, Pavelka K, Housa D, Haluzik M. Increased adiponectin is negatively linked to the local inflammatory process in patients with rheumatoid arthritis. Cytokine 2006;35:247–52.
   PubMed Web of Science ®Google Scholar
• Kreiner F, Galbo H. Insulin sensitivity and related cytokines, chemokines, and adipokines in polymyalgia rheumatica. Scand J Rheumatol 2010;39:402–8.
   PubMed Web of Science ®Google Scholar